Dr. Rebecca Adams -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Rebecca Adams, a Internal Medicine physician based in City, LA. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Rebecca Adams has received $1,271.14 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

  • Full Name: Dr. Rebecca Adams
  • Medical Specialty: Internal Medicine
  • Practice Location: City, LA, Louisiana
  • NPI Number: 1389211505
  • Transparency Score: 50/100
  • Payment Records Span: 2025-04-08 to 2025-04-08

Payment Summary

Dr. Rebecca Adams has received a total of $1,271.14 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $1,271.14 per transaction.

  • Total Payments Received: $1,271.14
  • Number of Transactions: 1
  • Average Payment: $1,271.14
  • Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Internal Medicine. A higher score indicates fewer or more routine payments.
  • Number of Pharma Relationships: 1 pharmaceutical companies

Payment Breakdown by Category

The following table shows how Dr. Rebecca Adams's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription

The largest payment category for Dr. Rebecca Adams is Speaking & Education, accounting for 0% ($0.00) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Rebecca Adams. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Johnson & Johnson$1,271.141

Dr. Rebecca Adams has a financial relationship with Johnson & Johnson, receiving $1,271.14 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Rebecca Adams's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Rebecca Adams has received $1.3K across 1 pharmaceutical payments as a Internal Medicine physician in City, LA. Top paying companies include Johnson & Johnson ($1.3K). Dr. Rebecca Adams received a single payment of $1,271 from Johnson & Johnson in 2025, which represents 100% of her total pharmaceutical payments. The payment was of a general nature and there is no trend data available beyond the single year of 2025.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Rebecca Adams is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that Dr. Rebecca Adams has received a single, substantial payment from Johnson & Johnson, but there is no indication of ongoing or repeated interactions. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Rebecca Adams Compares to Other Internal Medicine Physicians

Compared to peers in Internal Medicine, Dr. Rebecca Adams has received a single, significant payment, which is less frequent than some of her colleagues who may have received multiple payments over time.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Rebecca Adams in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Johnson & Johnson$1,271.14generalN/A2025-04-08Not Assessed

Frequently Asked Questions About Dr. Rebecca Adams's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Rebecca Adams received?

Rebecca Adams has received a total of $1.3K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Rebecca Adams taking too much pharma money?

Rebecca Adams has received $1.3K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Internal Medicine), the types of payments, and how they compare to peers. The largest payment category is general ($1.3K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Rebecca Adams?

The top pharmaceutical companies paying Rebecca Adams are: Johnson & Johnson ($1.3K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Rebecca Adams receive?

Rebecca Adams's payments by type: general: $1.3K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Rebecca Adams's payments compare to other Internal Medicine doctors?

To compare, look at the total amount ($1.3K), number of payments (1), and the types of payments received. Internal Medicine physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Rebecca Adams's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1389211505). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Rebecca Adams's pharma payment profile?

The payment is from a well-known pharmaceutical company, Johnson & Johnson. Rebecca Adams has received $1.3K in total pharma payments.

How does Rebecca Adams compare to peers in Internal Medicine?

Compared to peers in Internal Medicine, Dr. Rebecca Adams has received a single, significant payment, which is less frequent than some of her colleagues who may have received multiple payments over time.

Are Rebecca Adams's pharma relationships typical for Internal Medicine?

The payment is the only one recorded for this doctor, indicating a lack of diversity in pharmaceutical interactions.

What should patients of Rebecca Adams know about these payments?

Consumers should be aware that Dr. Rebecca Adams has received a single, substantial payment from Johnson & Johnson, but there is no indication of ongoing or repeated interactions.

What patterns are visible in Rebecca Adams's payment history?

The payment amount is significant, which could be of interest to stakeholders.

Understanding This Doctor Payment Report

This transparency report for Dr. Rebecca Adams is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

  • Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
  • Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
  • Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Internal Medicine physicians may have very different payment norms than physicians in other fields.
  • Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
  • Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Rebecca Adams's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Rebecca Adams and all other physicians can be accessed at the official CMS Open Payments website.

Other Internal Medicine Physicians

Compare Dr. Rebecca Adams's pharmaceutical payments with other Internal Medicine physicians ranked by total pharma payments received.

PhysicianStateTotal Payments
Karen HarrisAL$373,560.30
Andrew YoungMN$373,004.12
Catherine MorrisMI$329,087.36
Benjamin CookAL$290,577.64
Patricia DavisIN$229,890.74
Karen HarrisPA$223,458.75
Charles BakerOH$174,454.86
Amanda LewisTN$161,516.05
Amanda LewisAL$145,697.34
Christine EdwardsTX$144,283.94

Top Doctors in Louisiana

These physicians in Louisiana have received the highest pharmaceutical payments. See how Dr. Rebecca Adams compares to peers in the same state.

PhysicianSpecialtyTotal Payments
Stephanie KingNeurology$308,624.53
Timothy RogersDermatology$300,324.91
Charles BakerCardiology$189,146.74
Amanda LewisPsychiatry$186,870.46
Jeffrey CampbellNeurology$174,169.56
Brian WrightOncology$163,512.80
Laura HallHematology$146,752.97
Michelle ScottOncology$135,372.63
David KimOncology$132,860.92
David KimGenetics$130,702.83

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.